Nootropics

Nicotinamide mononucleotide

Some human metabolic and functional signals exist, but no cited trial establishes longer life or a universal anti-aging effect.

Small randomized human trials with surrogate endpoints

Nicotinamide mononucleotide molecular structure — Structure reference · C11H15N2O8P

Practical use

Applying the explained evidence

Where it fits: Some human metabolic and functional signals exist, but no cited trial establishes longer life or a universal anti-aging effect.
Put the information into practice: Positive endpoints deserve context beside unchanged ones. Studies in postmenopausal women, recreational runners and middle-aged adults are not interchangeable populations.
Make the claim measurable: Specify the claimed effect: alertness, memory, attention or another outcome. Check whether researchers measured that outcome directly; a mechanism or a subjective feeling is a different kind of evidence.
Keep this limit in view: The reported improvements concerned selected threshold measures; maximal uptake did not improve correspondingly.

Prediabetes and muscle insulin sensitivity

Six-week amateur-runner trial

Overview

NMN is a precursor in NAD metabolism. Increasing NAD-related measurements, improving an exercise threshold and extending human life are three different propositions; only the first two have been tested in the studies below.

Risks and limitations

Short trials reported tolerability in selected adults, but cannot determine years-long risk or safety across illnesses and drug combinations. A commercial product name does not establish equivalent purity or clinical performance.

How to read this

Positive endpoints deserve context beside unchanged ones. Studies in postmenopausal women, recreational runners and middle-aged adults are not interchangeable populations.

Research explained

Muscle insulin sensitivity

Who was studied

Overweight or obese postmenopausal women with prediabetes; ten-week randomized double-blind trial.

What was found

Insulin-stimulated glucose disposal and muscle insulin signaling improved after NMN, while placebo did not show the same changes.

What it cannot establish

Mechanistic metabolic endpoints, not a diabetes-remission or survival trial. The accessed abstract does not state sample size or the numerical effect.

Read the original study

Exercise thresholds versus maximal capacity

Who was studied

48 recreational runners; four randomized groups, six weeks of training.

Participants: 48 participants
Study duration: 6 weeks

What was found

Selected ventilatory-threshold measurements improved more in two active groups. VO2max, oxygen pulse and peak power did not show corresponding improvement.

What it cannot establish

Twelve people per arm, short duration and multiple outcomes. A threshold result must not be relabeled as increased VO2max.

Read the original study

Blood NAD and walking outcomes

Who was studied

80 middle-aged adults; four randomized groups over sixty days, all completed.

What was found

Blood NAD and six-minute-walk outcomes favored active groups; HOMA-IR did not significantly differ from placebo. No safety issues were identified during monitoring.

What it cannot establish

Short per-protocol study. Its algorithm-derived biological-age measure is not observed slowing of aging or extended lifespan.

Read the original study

Blood and muscle are distinct compartments

The prediabetes study used a glucose clamp and muscle signaling measurements. A commercial blood NAD result is not automatically an equivalent test.

Supporting source

Fitness has multiple dimensions

Ventilatory thresholds and maximal oxygen uptake are different outputs. Reporting only a broad “aerobic capacity” headline conceals the null measures.

Supporting source

A biological-age calculator is not survival

The sixty-day study used a model-derived score. That score cannot tell how many years a person will live.

Supporting source

Regulatory records are not efficacy approval

FDA’s notification list includes a beta-NMN ingredient submission. A notification entry does not constitute an FDA-approved treatment claim or validation of every product.

Supporting source